Ask Indegene Icon

Ask Indegene (Beta)

Online
🧠 Building on our previous conversation...

Hello, how can I help you today?

You may type your question or choose from the options below:

Explore Solutions
Browse Insights
View Case Studies
Read Latest News
Explore Careers
Connect with an Expert
Please enter your full name
Please enter a valid work email
Please enter your message

Thank you!

We'll be in touch. In the meantime, feel free to keep exploring!

#PractitionerLevelConfidence

Indegene
Search Icon
Indegene ensures compliance with clinical trial submission requirements ​
Home
What we think
Case studies

Indegene ensures compliance with clinical trial submission requirements ​

The Customer

A global pharmaceutical company creating a future where disease is a thing of the past by fighting sickness with science, improving access with ingenuity, and healing hopelessness with heart. It focuses on specific therapies where it makes the biggest difference - cardiovascular and metabolism, immunology, infectious diseases and vaccines, immunology, infectious diseases and vaccines, neuroscience, oncology, and pulmonary hypertension..

Challenges

  • Managing multiple stakeholders in the regulatory planning and submission process delaying the process​

    Low compliance for health authority query responses​

    Non-comprehensive intelligence on multiple European markets​

The Solution

Indegene deployed a team with deep knowledge of European clinical trial and regulatory requirements in a flexible operating model.

We seamlessly integrated Indegene SMEs and experts with client systems and processes, trained on their internal SOPs.

We scaled our team to manage entire CTA lifecycle (prepare, compile, submit, archive) on behalf of the client.

Outcomes

Indegene furthered this client’s goal of creating a future where disease is a thing of the past by enabling its regulatory operations be fully compliant, improving effectiveness and efficiency, and being future ready

We ensured 100% compliance to regulatory guidelines, 99.5% right first-time submissions and 100% adherence to internal metrics

0%

Compliance to regulatory guidelines

0%

Right first-time submissions

0%

Adherence to internal metrics

Let's Partner to Commercialize with Confidence

Powered by Onetrust